|
 |
S-PAC-1 Targeting Cellular Enzyme Procaspase-3 Shows Promise in Canine Lymphoma, Providing Optimizism for Effects in Humans
Researchers have identified a new target for the treatment of lymphoma and are testing a potential new drug in pet dogs afflicted with the disease.
Personalized Medicine: Molecular Imaging Predicts Treatment Success in Many Cancers
A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma.
Diverse Diet of Vegetables May Decrease Lung Cancer Risk
Adding a variety of vegetables to ones diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers.
Copenhagen Researchers Activate Anti-Cancer Gene CDX2 in Colon Cancer Study
Researchers at the Faculty of Health Sciences at the University of Copenhagen have succeeded in decoding the genetic key that gives particular intestinal cells their identity.
Double-Therapy Approach Effectively Inhibited Brain Cancer Recurrence?
Researchers from the University of Massachusetts Medical School have identified a novel approach of combining chemotherapy with a targeted therapy to decrease the recurrence of glioblastoma multiforme, the most common and aggressive brain tumor.
Cost of Prostate Cancer Care Varies with Initial Treatment Choices
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives.
Merrimack Pharmaceuticals and sanofi-aventis Initiate Enrollment in a Phase 2 Combination Study of MM-121 and exemestane in Breast Cancer
Merrimack Pharmaceuticals, Inc. and sanofi-aventis have announced that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasinฎ) in breast cancer patients.
Are new colon cancer drugs worth the cost?
ATLANTA March 16, 2010 (cancerfacts.com) One of the least discussed aspects of the current healthcare debate is the actual cost of treatments, and few studies ever include cost in the considerations of the benefits of those treatments.
Lung cancer drug fails to improve survival
NEW YORK March 11, 2010 (cancerfacts.com) Pfizer Inc. announced today it is suspending a large clinical trial of its lung-cancer drug.
Obesity linked to poor colon cancer prognosis
PHILADELPHIA March 9, 2010 Obese patients with colon cancer are at greater risk for death or recurrent disease compared to those who are within a normal weight range, according to a report in Clinical Cancer Research.
Colorectal drug fails to boost survival
LONDON Mar. 8, 2010 Anglo-Swedish pharmaceutical company, AstraZeneca, reported on Monday that its colorectal cancer drug failed to show that it is better than a competitor's drug.
New biomarkers for predicting the spread of colon cancer
HANGZHOU, China Mar. 8, 2010 (cancerfacts.com) Two proteins present in the blood of people with colon cancer may accurately serve as markers to predict whether the disease will spread, say scientists in China.
Common osteoporosis drugs may prevent breast cancer
SEATTLE Mar. 2, 2010 (cancerfacts.com) Women who take some types of drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a new study.
Breast removal may only reduce cancer risk for younger women
HOUSTON Feb. 25, 2010 (cancerfacts.com) Women over 60 with early stage cancer in only one breast need not consider removal of the unaffected breast to prevent a recurrence, say researchers.
Statin use may slow prostate cancer progression
DURHAM, North Carolina Feb. 24, 2010 Men who took statins to lower their cholesterol before prostate cancer surgery had significantly lower inflammation within prostate tumors, new research shows.
Prostate cancer diagnosis boosts suicide rate for some
STOCKHOLM Feb. 23, 2010 (cancerfacts.com) Swedish men diagnosed with advanced or metastatic prostate cancer had a suicide rate that was twice as high compared with the general male population, according to a new study.
Open and laparoscopic prostate surgery equal
NEW YORK, NY Feb. 22, 2010 (cancerfacts.com) Men diagnosed with operable prostate cancer can expect similar outcomes regardless of whether they choose conventional open surgery or newer robotic assisted surgery, a new study shows.
Aspirin cut breast cancer spread and death by half
BOSTON Feb. 17, 2010 (cancerfacts.com) Women who completed treatment for early-stage breast cancer and who took aspirin had a nearly 50 percent lower risk of dying of breast cancer, a new data analysis shows.
It may never be too late to quit smoking
LONDON Feb. 15, 2010 Contrary to what many people diagnosed with lung cancer might think, it is not too late to benefit from quitting smoking.
Working in working out
HOUSTON Feb. 12, 2010 (cancerfacts.com) Most people know that getting at least 30 minutes of exercise every day reduces their risk of developing some types of cancer.
|
|
|
|
|
|
